Cargando…
Glucose transporter 1 deficiency, AMP-activated protein kinase activation and immune dysregulation in autism spectrum disorder: Novel biomarker sources for clinical diagnosis
The neurophysiological basis of autism spectrum disorder (ASD) is still uncertain. Nevertheless, studies support the hypotheses that oxidative stress, neuroinflammation, immune dysregulation, and metabolic stress are contributors. In this study, the serum levels of 3-nitrotyrosine (3-NT), hypoxia-in...
Autor principal: | Al-Bishri, Widad M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654234/ https://www.ncbi.nlm.nih.gov/pubmed/38020228 http://dx.doi.org/10.1016/j.sjbs.2023.103849 |
Ejemplares similares
-
Neuronal Glucose Transporter Isoform 3 Deficient Mice Demonstrate Features of Autism Spectrum Disorders
por: Zhao, Yuanzi, et al.
Publicado: (2009) -
Hypothalamic AMP-Activated Protein Kinase Regulates Glucose Production
por: Yang, Clair S., et al.
Publicado: (2010) -
Berberine Promotes Glucose Consumption Independently of AMP-Activated Protein Kinase Activation
por: Xu, Miao, et al.
Publicado: (2014) -
Molecular Dysregulation in Autism Spectrum Disorder
por: Gill, Pritmohinder S., et al.
Publicado: (2021) -
Hypothalamic AMP-activated Kinase Regulates Glucose-stimulated Insulin Secretion
por: Koh, Eun Hee, et al.
Publicado: (2016)